Hong Kong Training Portal on
Infection Control and Infectious Disease

Conditional Approval of Registration of Remdesivir

Coronavirus (COVID-19) Update: FDA Issued Emergency Use Authorization for Point of Care Antigen Test

FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Potential Risks Associated With The Use of Ozone and Ultraviolet (UV) Light Products for Cleaning CPAP Machines and Accessories: FDA Safety Communication

Alert on the cluster of pneumonia cases in Wuhan of Mainland

First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response

Reporting of Burkholderia cepacia complex. Centre for Health Protection, Letter to Doctor

Spain Issues International Warning over Listeriosis Outbreak

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern

Reporting of Candida auris, Centre for Health Protection. Letter to Hospital

Important Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms

Tuberculosis and Mycobacterial Infections: An Educational Update Singapore 26 – 28 September 2019

First FDA-approved vaccine for the prevention of dengue disease in endemic regions

World Immunization Week

Measles cases rose nearly four-fold in first quarter 2019: WHO

Update on the Situation of Measles and the Recommended Schedule of Measles-containing Vaccine in Childhood Immunisation Programm

Scientific recommendations on pertussis vaccination for pregnant women in Hong Kong

Educational video on Control of MDROs in Hong Kong

Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics